Showing results (3801-3810 of 6,740) with videos related to

Sort By:
Pageof 674
Oncotargets and Therapy|June 6, 2013
Abundance of Flt3 and its ligand in astrocytic tumorsC Eßbach, N Andrae, D Pachow, et al.
Oncotargets and Therapy|June 6, 2013
Nanoparticle albumin-bound paclitaxel combined with cisplatin as the first-line treatment for metastatic esophageal squamous cell carcinomaYan Shi, Rui Qin, Zhi-Kuan Wang, et al.
Oncotargets and Therapy|May 10, 2012
The effect of anti-VEGF drugs (bevacizumab and aflibercept) on the survival of patients with metastatic colorectal cancer (mCRC)Kuifeng He, Binbin Cui, Guangliang Li, et al.
Oncotargets and Therapy|October 5, 2013
Resveratrol decreases B-cell lymphoma-2 expression and viability in GH3 pituitary adenoma cells of the ratBenjamin Voellger, Elmar Kirches, Annette Wilisch-Neumann, et al.
Oncotargets and Therapy|October 8, 2013
The relationship between Lin28 and the chemotherapy response of gastric cancerRong Yue Teng, Ji Chun Zhou, Zi Nong Jiang, et al.
Oncotargets and Therapy|October 17, 2017
HIF pathway and c-Myc as biomarkers for response to sunitinib in metastatic clear-cell renal cell carcinomaP Maroto, E Esteban, E Fernández Parra, et al.
Oncotargets and Therapy|October 17, 2017
Sitting time and occupational and recreational physical activity in relation to the risk of esophageal squamous cell carcinomaPengxiang Chen, Qingxu Song, Jie Han, et al.
Oncotargets and Therapy|October 17, 2017
Is this the end of cytotoxic chemotherapy in Merkel cell carcinoma?Guilherme Rabinowits
Oncotargets and Therapy|October 19, 2017
Significant association of the EXO1 rs851797 polymorphism with clinical outcome of ovarian cancerTingyan Shi, Rong Jiang, Pan Wang, et al.
Oncotargets and Therapy|October 19, 2017
Crizotinib, a MET inhibitor, inhibits growth, migration, and invasion of breast cancer cells in vitro and synergizes with chemotherapeutic agentsNehad M Ayoub, Kamal M Al-Shami, Mohammad A Alqudah, et al.
Pageof 674